ELGN-EYE
Prevention of retinopathy of prematurity
Phase 2Active
Key Facts
About Elgan Pharma
Israeli biotech developing non‑invasive, organ‑targeted therapies for preterm infants with unmet clinical needs.
View full company profilePrevention of retinopathy of prematurity
Israeli biotech developing non‑invasive, organ‑targeted therapies for preterm infants with unmet clinical needs.
View full company profile